top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
CATALOG NO | SPECIES | ANATOMIC SITE | ANATOMIC SYSTEM | PATHOLOGY | STATUS | PRICE |
|---|---|---|---|---|---|---|
BRE01 | Human | Breast | Breast | Normal breast | Current | $160 |
BRE02 | Human | Breast | Breast | Hyperplasia | Current | $160 |
BRE03 | Human | Breast | Breast | Fibrocystic disease | Current | $160 |
BRE04 | Human | Breast | Breast | Fibroadenoma | Current | $160 |
BRE05 | Human | Breast | Breast | Ductal carcinoma in situ | Current | $181 |
BRE06 | Human | Breast | Breast | Invasive ductal carcinoma | Current | $160 |
BRE07 | Human | Breast | Breast | Invasive lobular carcinoma | Current | $181 |
BRE08 | Human | Breast | Breast | Paget's disease | Current | $198 |
BRE09 | Human | Breast | Breast | Lobular carcinoma in situ | Current | $235 |
BRE10 | Human | Breast | Breast | Hyperplasia, ADH | Current | $198 |
BRE11 | Human | Breast | Breast | Hyperplasia, ALH | Current | $198 |
BRE12 | Human | Breast | Breast | Adenosis | Current | $198 |
BRE13 | Human | Breast | Breast | Invasive ductal carcinoma
| Current | $392 |
bottom of page